LINCS Pilot Phase Joint Project: Sensitivity measures of six breast cancer cell lines to a library of small molecule kinase inhibitors (single drug treatments). Dataset 1 of 15: Cell count and relative growth within biological replicate 1. - Dataset (ID:20237)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration | Small Mol Conc Unit | LJP Library Plate | Replicate | Assay Well | Timepoint | Timepoint Unit | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Relative Growth Rate After Treatment |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| MDA-MB-231 | A443654 | 1.11 | uM | LJP6 | 1 | I21 | 72 | hr | 868 | 751 | 3486 | 0.2154 | -0.0447 |
| MDA-MB-231 | A443654 | 1.11 | uM | LJP6 | 2 | I21 | 72 | hr | 868 | 588 | 3486 | 0.1687 | -0.1070 |
| MDA-MB-231 | A443654 | 1.11 | uM | LJP6 | 3 | I21 | 72 | hr | 868 | 560 | 3486 | 0.1606 | -0.1177 |
| MDA-MB-231 | OSI-027 | 1.11 | uM | LJP6 | 1 | E09 | 72 | hr | 868 | 2601 | 3486 | 0.7460 | 0.6618 |
| MDA-MB-231 | OSI-027 | 1.11 | uM | LJP6 | 2 | E09 | 72 | hr | 868 | 2499 | 3486 | 0.7168 | 0.6229 |
| MDA-MB-231 | OSI-027 | 1.11 | uM | LJP6 | 3 | E09 | 72 | hr | 868 | 2482 | 3486 | 0.7119 | 0.6164 |
| MDA-MB-231 | XMD11-85h | 1.11 | uM | LJP6 | 1 | P21 | 72 | hr | 868 | 2615 | 3486 | 0.7501 | 0.6672 |
| MDA-MB-231 | XMD11-85h | 1.11 | uM | LJP6 | 2 | P21 | 72 | hr | 868 | 2772 | 3486 | 0.7951 | 0.7272 |
| MDA-MB-231 | XMD11-85h | 1.11 | uM | LJP6 | 3 | P21 | 72 | hr | 868 | 2769 | 3486 | 0.7942 | 0.7260 |
| MDA-MB-231 | HG-6-64-01 | 1.11 | uM | LJP6 | 1 | M03 | 72 | hr | 868 | 1684 | 3486 | 0.4830 | 0.3116 |
| MDA-MB-231 | HG-6-64-01 | 1.11 | uM | LJP6 | 2 | M03 | 72 | hr | 868 | 1720 | 3486 | 0.4934 | 0.3254 |
| MDA-MB-231 | HG-6-64-01 | 1.11 | uM | LJP6 | 3 | M03 | 72 | hr | 868 | 1644 | 3486 | 0.4716 | 0.2963 |
| MDA-MB-231 | WH-4-025 | 1.11 | uM | LJP5 | 1 | O09 | 72 | hr | 868 | 657 | 3486 | 0.1885 | -0.0806 |
| MDA-MB-231 | WH-4-025 | 1.11 | uM | LJP5 | 2 | O09 | 72 | hr | 868 | 804 | 3486 | 0.2306 | -0.0245 |
| MDA-MB-231 | WH-4-025 | 1.11 | uM | LJP5 | 3 | O09 | 72 | hr | 868 | 851 | 3486 | 0.2441 | -0.0065 |
| MDA-MB-231 | WZ-4-145 | 1.11 | uM | LJP6 | 1 | J21 | 72 | hr | 868 | 2727 | 3486 | 0.7822 | 0.7100 |
| MDA-MB-231 | WZ-4-145 | 1.11 | uM | LJP6 | 2 | J21 | 72 | hr | 868 | 2634 | 3486 | 0.7555 | 0.6744 |
| MDA-MB-231 | WZ-4-145 | 1.11 | uM | LJP6 | 3 | J21 | 72 | hr | 868 | 2657 | 3486 | 0.7621 | 0.6832 |
| MDA-MB-231 | XMD16-144 | 1.11 | uM | LJP5 | 1 | M09 | 72 | hr | 868 | 1284 | 3486 | 0.3683 | 0.1588 |
| MDA-MB-231 | XMD16-144 | 1.11 | uM | LJP5 | 2 | M09 | 72 | hr | 868 | 1338 | 3486 | 0.3838 | 0.1795 |
| MDA-MB-231 | XMD16-144 | 1.11 | uM | LJP5 | 3 | M09 | 72 | hr | 868 | 1309 | 3486 | 0.3755 | 0.1684 |
| MDA-MB-231 | Brivanib | 1.11 | uM | LJP5 | 1 | P15 | 72 | hr | 868 | 2879 | 3486 | 0.8258 | 0.7680 |
| MDA-MB-231 | Brivanib | 1.11 | uM | LJP5 | 2 | P15 | 72 | hr | 868 | 3118 | 3486 | 0.8943 | 0.8593 |
| MDA-MB-231 | Brivanib | 1.11 | uM | LJP5 | 3 | P15 | 72 | hr | 868 | 2993 | 3486 | 0.8585 | 0.8116 |
| MDA-MB-231 | Buparlisib | 1.11 | uM | LJP5 | 1 | H03 | 72 | hr | 868 | 1802 | 3486 | 0.5169 | 0.3567 |